COST EFFECTIVENESS OF PEMETREXED/CISPLATIN (PEM/CIS) IN THE TREATMENT OF ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSQNSCLC) PATIENTS

被引：0
|
作者：
Winfree, K. B. [1 ]
Shah, M. [2 ]
Peterson, P. [3 ]
Gruschkus, S. [2 ]
Eaddy, M. [2 ]
Green, M. [2 ]
机构：
[1] Eli Lilly & Co, Global Hlth Outcomes Oncol, Indianapolis, IN 46285 USA
[2] Xcenda AmerisourceBergen Consulting Serv, Oncol, Palm Harbor, FL USA
[3] Eli Lilly & Co, Oncol Stat, Indianapolis, IN 46285 USA
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [31] TOLERANCE AND EFFICACY OF CHEMOTHERAPY WITH PLATINUM AND PEMETREXED IN ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Leprieur, Etienne Giroux
    Labrune, Sylvie
    Giraud, Violaine
    Gendry, Thierry
    Cobarzan, Daniel
    Chinet, Thierry
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1285 - S1286
  • [32] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
  • [33] RETROSPECTIVE STUDY OF COMBINATION CHEMOTHERAPY WITH CISPLATIN PLUS PEMETREXED AS FIRST LINE THERAPY FOR ADVANCED NON-SMALL CELL NON-SQUAMOUS LUNG CANCER
    Inui, Toshiya
    Yokoyama, Takuma
    Takata, Saori
    Hirata, Aya
    Nishizawa, Tomotaka
    Hirukawa, Ichiro
    Wada, Hiroo
    Ishii, Haruyuki
    Takizawa, Hajime
    Goto, Hajime
    [J]. RESPIROLOGY, 2013, 18 : 149 - 149
  • [34] COST COMPARISON OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE VERSUS PEMETREXED AND CISPLATIN THERAPY IN PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL CANCER IN GERMANY - AN UPDATED ANALYSIS
    Bischoff, H. G.
    Hermes, A.
    Heigener, D. F.
    Cesaro-Tadic, S.
    Walzer, S.
    Nuijten, M.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A39 - A39
  • [35] Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer
    Melosky, Barbara
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [36] CLINICAL INVESTIGATION OF CISPLATINE/PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
    Watanabe, K.
    Okuma, Y.
    Nakahara, Y.
    Yomota, M.
    Takagi, Y.
    Hosomi, Y.
    Okamura, T.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 86 - 86
  • [37] PHARMACOKINETIC (PK) ANALYSIS OF COADMINISTRATION OF AXITINIB AND PEMETREXED/CISPLATIN (PEM/CIS) IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC).
    Tortorici, M. A.
    Iglesias, L.
    Kozloff, M. F.
    Pithavala, Y. K.
    Ingrosso, A.
    Belani, C. P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S33 - S33
  • [38] CARBOPLATIN AND PEMETREXED FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - OVERALL SURVIVAL AND TOXICITY
    Andersen, R.
    Mellemgaard, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S73 - S73
  • [39] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    [J]. LUNG CANCER, 2019, 129 : 35 - 40
  • [40] ORAL VINORELBINE PLUS CISPLATIN VERSUS PEMETREXED PLUS CISPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER: A COST MINIMIZATION ANALYSIS IN TWELVE EUROPEAN COUNTRIES
    Bucher, D.
    Grossi, F.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A446 - A446
12345